Image Credit: STAT News

STAT+: AstraZeneca, Daiichi Sankyo change strategy on closely watched cancer drug

Watchdoq November 12, 2024

A closely watched cancer drug from AstraZeneca and Daiichi Sankyo could take longer to reach the market.